prof. dr. B. (Bob) Wilffert

Head of Department PharmacoTherapy, -Epidemiology and -Economics

Research

Postal address:
A Deusinglaan
1
Gebouw 3214, ruimte 0466
Groningen
Netherlands
Phone: +31 50 363 7576
  1. 2010
  2. 2009
  3. Van Zanden, J. J., Lacor, M., Wilffert, B., Kingma, P., & McLaughlin, P. M. J. (2009). Een man met flecaïnide-intoxicatie. Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde, 34(4), 262-263.
  4. Al Hadithy, A. F. Y., Ivanova, S. A., Pechlivanoglou, P., Semke, A., Fedorenko, O., Kornetova, E., ... Loonen, A. J. M. (2009). Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 33(3), 475-481. https://doi.org/10.1016/j.pnpbp.2009.01.010
  5. Yska, J. P., van Zanten, E., & Wilffert, B. (2009). Manufacturing study medication for clinical trials. Ejhp practice, 15(6), 63-64.
  6. 2008
  7. Swen, J. J., Wilting, I., Goede, AL. D., Grandia, L., Mulder, H., Touw, D. J., ... Deneer, V. H. M. (2008). Pharmacogenetics: From bench to byte. Clinical Pharmacology & Therapeutics, 83(5), 781-787. https://doi.org/10.1038/sj.clpt.6100507
  8. 2007
  9. 2005
  10. 2004
  11. 2003
  12. 1999
  13. Van Vliet, A. A., Wemer, J., Wilffert, B., De Vroedt, J. W. P., & Jonkman, J. H. G. (1999). Informed consent in healthy volunteers: Whom does it protect? Good Clinical Practice Journal, 6(1), 23-26.
  14. Oosterhuis, B., Tamminga, W. J., Wemer, J., Wieling, J., Wilffert, B., Sakiman, E. P., ... Jonkman, J. H. G. (1999). Mephenytoin as a marker for CYP2C19 enzyme activity: influence of analytical factors on teh outcome of phenotyping. In A. R. Boobis, P. Kremers, O. Pelkonen, & K. Pithan (Eds.), Proceedings European Symposium on the prediction of drug metabolism in man: progress and problems (pp. 197 - 200). Luxembourg: Office for official publications of the european communities.
  15. 1998
  16. Gutser, UT., Friese, J., Heubach, JF., Matthiesen, T., Selve, N., Wilffert, B., & Gleitz, J. (1998). Mode of antinociceptive and toxic action of alkaloids of Aconitum spec. Naunyn-Schmiedebergs Archives of Pharmacology, 357(1), 39-48.
  17. 1997
  18. Friese, J., Gleitz, J., Gutser, UT., Heubach, JF., Matthiesen, T., Wilffert, B., & Selve, N. (1997). Aconitum sp. alkaloids: the modulation of voltage-dependent Na+ channels, toxicity and antinociceptive properties. European Journal of Pharmacology, 337(2-3), 165-174.
  19. Wemer, J., Tamminga, W. J., Oosterhuis, B., Wilffert, B., Jonkman, J. H. G., de Leij, L., ... Meulenbelt, J. (1997). Genotypering in relation to pharmacokinetics and pharmacodynamics. Conceptuur, 34 - 36.
  20. 1996
  21. Frink, MC., Hennies, HH., Englberger, W., Haurand, M., & Wilffert, B. (1996). Influence of tramadol on neurotransmitter systems of the rat brain. Arzneimittel-Forschung/drug research, 46(11), 1029-1036.
  22. Selve, N., Englberger, W., Friderichs, E., Hennies, HH., Reimann, W., & Wilffert, B. (1996). Galanin receptor antagonists attenuate spinal antinociceptive effects of DAMGO, tramadol and non-opioid drugs in rats. Brain Research, 735(2), 177-187.
  23. 1995
  24. 1994
  25. 1993

ID: 218810